Literature DB >> 22089837

Breast cancer: overview & updates.

Catherine Downs-Holmes1, Paula Silverman.   

Abstract

Breast cancer is a complex disease and treatment recommendations are continually changing. It is the leading cancer in women and the second leading cause of cancer mortality. This overview of breast cancer will discuss pathologic features, local and systemic treatment considerations, endocrine therapy, metastatic treatment regimens, and follow-up for optimal breast health. Recent approvals that advance the treatment of metastatic breast cancer are also addressed.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22089837     DOI： 10.1097/01.NPR.0000407602.29522.d7

Source DB:  PubMed          Journal:  Nurse Pract        ISSN： 0361-1817


  18 in total

1.  Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.

Authors:  Catherine M Bender; Amanda L Gentry; Adam M Brufsky; Frances E Casillo; Susan M Cohen; Meredith M Dailey; Heidi S Donovan; Jacqueline Dunbar-Jacob; Rachel C Jankowitz; Margaret Q Rosenzweig; Paula R Sherwood; Susan M Sereika
Journal:  Oncol Nurs Forum       Date:  2014-05       Impact factor: 2.172

2.  Polymorphism of 8q24 rsl3281615 and breast cancer risk : a meta-analysis.

Authors:  Yan-Lei Pei; He-Long Zhang; Hong-Guang Han
Journal:  Tumour Biol       Date:  2012-11-07

Review 3.  Choices in surgery for older women with breast cancer.

Authors:  Vikram Swaminathan; Markos K Spiliopoulos; Riccardo A Audisio
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

4.  Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches.

Authors:  T Jazedje; A L Ribeiro; M Pellati; H M de Siqueira Bueno; G Nagata; M Trierveiler; E G Rodrigues; M Zatz
Journal:  Stem Cells Int       Date:  2015-04-27       Impact factor: 5.443

5.  Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts.

Authors:  Shanbeh Zienolddiny; Aage Haugen; Jenny-Anne Sigstad Lie; Helge Kjuus; Kristine Haugen Anmarkrud; Kristina Kjærheim
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

6.  Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

Authors:  Sherif A Ibrahim; Hebatallah Hassan; Laura Vilardo; Sampath Katakam Kumar; Archana Vijaya Kumar; Reinhard Kelsch; Cornelia Schneider; Ludwig Kiesel; Hans Theodor Eich; Ileana Zucchi; Rolland Reinbold; Burkhard Greve; Martin Götte
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Hepatoma upregulated protein expression is involved in the pathogenesis of human breast carcinogenesis.

Authors:  Jin Chen; Qiu-Jun Liu; DA Wang; Xian-Yao Zhou; Ding Xiong; Hong-Jiang Li; Chang-Long Li
Journal:  Oncol Lett       Date:  2014-10-13       Impact factor: 2.967

8.  Cytotoxic potential of Anisochilus carnosus (L.f.) wall and estimation of luteolin content by HPLC.

Authors:  Jaykumar Bhagat; Richard Lobo; Nimmy Kumar; Jessy Elizabeth Mathew; Aravinda Pai
Journal:  BMC Complement Altern Med       Date:  2014-10-28       Impact factor: 3.659

9.  A neglected issue on sexual well-being following breast cancer diagnosis and treatment among Chinese women.

Authors:  Fengliang Wang; Fei Chen; Xiqian Huo; Ruobing Xu; Liang Wu; Jianming Wang; Cheng Lu
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

10.  Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.

Authors:  Ge Qin; Fei Xu; Tao Qin; Qiufan Zheng; Dingbo Shi; Wen Xia; Yun Tian; Yanlai Tang; Jingshu Wang; Xiangshen Xiao; Wuguo Deng; Shusen Wang
Journal:  Oncotarget       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.